BGI Group

Chinese genome sequencing company

Follow BGI Group on Notably News to receive short updates to your email — rarely!

April 2024 The United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party requested an explanation from the Department of Defense regarding why BGI subsidiaries Innomics and STOmics were not included in the Department of Defense's list of Chinese military companies operating in the U.S.
2023 BGI and a scientific consortium jointly published a primate brain cell atlas.
March 2023 The United States Department of Commerce added BGI Research and BGI Tech Solutions (Hongkong) to the Entity List, citing allegations of surveillance and repression of ethnic minorities.
2022 BGI released the first research findings from a consortium of scientific users of the Stereo-seq technology.
2022 BGI led research publishing the world's first spatiotemporal map of axolotl brain regeneration.
2022 BGI, Northeast Forestry University, and other institutions revealed the genomics consequences of inbreeding in the South China tiger by examining its chromosome-scale genomes.
October 2022 The United States Department of Defense added BGI Genomics Co to its list of 'Chinese military companies' operating in the U.S.
July 2022 Illumina, MGI Tech Co., and Complete Genomics settled US patent litigation, with Illumina agreeing to pay $325 million. The settlement included a patent license for Illumina and a mutual agreement to not sue each other for patent or antitrust violations in the United States for three years.
May 2022 A US court ordered Illumina to pay US$333.8 million to BGI Group, finding that Illumina infringed two of BGI's patents and had done so willfully.
2021 BGI developed Stereo-seq, a genome-wide Spatial transcriptomics technology.
2021 State-owned enterprises of State Development and Investment Corporation and China Merchants Group took ownership stakes in BGI Genomics.
December 1 2021 The University of Copenhagen officially commented on the Reuters report about BGI's potential military-related research.
November 2021 Reuters reported that University of Copenhagen professor Guojie Zhang, employed by BGI, was developing drugs for the PLA to help soldiers manage altitude sickness.
August 2021 The UK announced a registration requirement with the Medicines and Healthcare products Regulatory Agency for BGI's prenatal tests.
July 2021 Reuters reported that BGI developed a prenatal test with PLA assistance, which also involved genetic data collection.
January 2021 Reuters reported BGI's collaboration with the People's Liberation Army (PLA) and affiliated institutions on projects to enhance soldiers' strength.
2020 BGI contributed to the completion of whole genome sequencing of 363 genomes covering 92.4% of bird families.
August 25 2020 Reuters reported an error where about 3,700 people in Sweden were incorrectly told they had coronavirus due to a fault in a BGI Genomics COVID-19 testing kit.
July 2020 The United States Department of Commerce's Bureau of Industry and Security placed two BGI subsidiaries on its Entity List, alleging human rights abuses related to genetic analysis work in Xinjiang.
July 2020 BGI returned a Paycheck Protection Program loan following media scrutiny.
April 2020 BGI Genomics reported distributing RT-PCR kits to more than 180 countries and regions for COVID-19 testing.
January 2020 BGI Genomics announced a real-time fluorescent RT-PCR kit to identify SARS-CoV-2, which was subsequently verified and authorized for use in 14 countries and regions, including emergency use listing by the World Health Organization.
2019 Illumina filed multiple patent infringement lawsuits against BGI Group, initiating a complex legal dispute in the genomic technology sector.
2019 A BGI subsidiary, Forensic Genomics International, was reported to have created a WeChat-enabled database of genetic profiles across the country.
May 2018 BGI reached an agreement with Mount Sinai Hospital in Toronto for the first installation of BGISEQ platforms in North America.
July 2017 BGI Genomics, a subsidiary of the group, made an initial public offering at the Shenzhen Stock Exchange.
May 2017 BGI announced the formation of West Coast Innovation Center, co-located in Seattle and San Jose, planning collaborations with University of Washington, Allen Institute for Brain Science, Bill & Melinda Gates Foundation, and Washington State University.
November 2016 BGI launched BGISEQ-50, a miniature version of their desktop sequencer.
September 2016 The China National GeneBank, opened by BGI and the Chinese Government, was established with 150 instruments of the BGISEQ-500 system.
October 2015 BGI launched BGISEQ-500, a desktop sequencing system that reportedly received over 500 orders and was developed to compete with Illumina's platforms.
May 2015 BGI signed a collaboration with Zhongshan Hospital's Center for Clinical Precision Medicine in Shanghai, which opened with a budget of ¥100 million. They became involved in China's US$9.2-billion 15-year medical research project.
2014 BGI collaborated with scientists from 20 countries to complete genome-wide sequencing of 48 bird species.
2013 BGI acquired Complete Genomics of Mountain View, California for US$118 million, after approval from the Committee on Foreign Investment in the United States.
2012 BGI began commercializing its services with investments from China Life Insurance Company, CITIC Group's Goldstone Investment, Jack Ma's Yunfeng Capital, and SoftBank China Capital. They launched their scientific journal GigaScience, partnering with BioMed Central.
2011 BGI reported employing 4,000 scientists and technicians with $192 million in revenue. The company completed genome sequencing for the deadly Germany E. coli O104:H4 outbreak in three days, releasing it under an open license.
2010 BGI purchased 128 Illumina HiSeq 2000 gene-sequencing machines with US$1.5 billion in collaborative funds from China Development Bank. BGI Americas was established in Cambridge, Massachusetts, and BGI Europe was established in Copenhagen, Denmark.

This contents of the box above is based on material from the Wikipedia article BGI Group, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also